On Oct 29, WHO published its annual Global Tuberculosis Report, with tuberculosis resuming its position as the top infectious ...

As of October 2024, WHO has validated 21 countries as having achieved trachoma elimination. Timothy Jesudason reports on the ...

Justyna Kowalska's upbringing behind the iron wall in then-communist Poland was not as bleak as people might imagine: she spent more time out playing than in front of the dull, black and white TV. But ...

We are writing to urgently highlight the unprecedented flooding that has devastated eastern Spain, particularly in the Valencia region, beginning on Oct 29, 2024. As of Nov 25, this catastrophic event ...

A world-renowned paediatric infectious disease specialist and advocate for health equity died on Sept 23, 2024.

IDWeek 2024 was held at the Los Angeles Convention Center in Downtown Los Angeles, CA, USA, from 16–19 October. Phoebe Hall reports.

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute exacerbations.1 For the past 60 years, systemic corticosteroids have been ...

Synthetic data, generated through artificial intelligence technologies such as generative adversarial networks and latent ...

The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...